- $638.65m
- $475.00m
- $106.94m
- 87
- 34
- 90
- 81
Annual income statement for Ceva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 100 | 123 | 121 | 97.4 | 107 |
| Cost of Revenue | |||||
| Gross Profit | 89.6 | 106 | 105 | 85.8 | 94.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 101 | 119 | 117 | 111 | 114 |
| Operating Profit | -0.763 | 3.51 | 3.9 | -13.5 | -7.54 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 2.52 | 5.69 | 4.2 | -8.21 | -2.75 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.38 | 0.396 | -13.9 | -18.4 | -8.79 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.38 | 0.396 | -23.2 | -11.9 | -8.79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.38 | 0.396 | -23.2 | -11.9 | -8.79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.108 | 0.017 | -0.499 | -0.782 | -0.372 |